CHAD CHITESTER: Open Payments
NPI 1184615163 · JAMESTOWN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$381 in 21 payments from 9 companies in 2025. Trend: 2023 $576 · 2024 $488 · 2025 $381
Food & beverage: $381
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 5 | $81 |
| Novo Nordisk Inc | 3 | $59 |
| AstraZeneca Pharmaceuticals LP | 3 | $55 |
| Boston Scientific Corporation | 2 | $47 |
| Dexcom, Inc. | 2 | $39 |
| ABBVIE INC. | 2 | $38 |
| Amgen Inc. | 2 | $30 |
| Janssen Pharmaceuticals, Inc | 1 | $19 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $15 |
Products named: FARXIGA, MOUNJARO, WATCHMAN FLX, Dexcom G6 Transmitter, JARDIANCE, OTEZLA, Ozempic, UBRELVY.
Industry payments across NY — which companies pay providers there.
